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Abstract In order to determine the effect of the lipid A analog,
E5531, on phospholipid membranes, we used dipalmitoylphos-
phatidylcholine (DPPC) and investigated the physicochemical
interaction between E5531 and DPPC membranes. E5531 and
DPPC are miscible in the bulk phase at 25‡C. Within the E5531
mole fraction range (XE5531) of 0^0.5, E5531 decreased the zeta
potentials of DPPC membranes but did not change the size of the
DPPC liposomes. E5531/DPPC mixtures formed liposome-like
structures. E5531 increased the fluidity of the DPPC membrane
and decreased pyrene diffusion in the membrane. E5531
decreased the phase transition temperature and the cooperative
interactions between DPPC molecules. These effects of E5531 on
phospholipid membranes were different from those of lipid A
from Escherichia coli and Salmonella minnesota.
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1. Introduction
Lipid A is a lipid anchor in lipopolysaccharide (LPS) that
exists on the outer membrane of Gram-negative bacteria. Lip-
id A induces undesirable toxic e¡ects such as fever and the
Schwartzmann bleeding reaction [1,2]. Recent research has
focused on the e¡ect of lipid A on the structural and dynamic
properties of membranes and revealed that most lipid A-in-
duced biological e¡ects are initiated by binding to a speci¢c
receptor [3,4] or by non-speci¢c intercalation into the lipid
matrix of the cell membrane [5]. The interaction and subse-
quent intercalation into the membrane are dependent on the
£uidity of the hydrophobic region and/or the supramolecular
structure of LPS and lipid A [6]. Rottem [7] has reported that
lipid A from Proteus mirabilis decreased the membrane £uid-
ity and permeability of phospholipid bilayers. Lei et al. [8]
have also reported that lipid A from Salmonella minnesota
decreased the membrane £uidity and raised the phase transi-
tion temperature of phospholipid membranes. In addition,
Benedetto et al. [9] have suggested that some of the e¡ects
produced by lipid A are mediated by a speci¢c molecular
reaction at the cell surface membrane and that the physico-
chemical properties of the membrane may be an important
determinant of the bioactivity of lipid A.
Recent research has also focused on the synthesis of lipid A
analogs with low toxicity. The synthetic disaccharide lipid A
analog E5531 (Fig. 1a) has low toxicity and retains various
useful biological activities (e.g. reduction of TNF production)
possessed by lipid A [10]. This compound has been found to
be a speci¢c LPS antagonist in an LPS-binding assay, and it
inhibits LPS-induced TNF production in monocytes/macro-
phages. Its anticipated use is as a drug for the treatment of
septic shock.
In order to investigate the e¡ect of E5531 on the cell surface
membrane, we used dipalmitoylphosphatidylcholine (DPPC)
as a model membrane and we investigated the physicochem-
ical properties using several techniques, monolayer to evaluate
the miscibility, zeta potentials, trapped volume of £uorescence
dye and £uorescence spectrometry to study the £uidity and
phase transition temperature of the membranes in the E5531/
DPPC mixtures. In addition, the e¡ect of E5531 on DPPC
membranes was compared with that for lipid A from Esche-
richia coli and Salmonella minnesota (Fig. 1b, Table 1).
2. Materials and methods
2.1. Materials
E5531 was obtained from Eisai (Ibaraki, Japan). The lipids A from
Escherichia coli F583 (Rd mutant) and Salmonella minnesota Re 595
(R mutants) were purchased from Sigma (St. Louis, MO, USA). Cal-
cein (3,3P-bis[N,N-bis(carboxymethyl)aminomethyl]-£uorescein) was
supplied by Dojin (Kumamoto, Japan). L-K-Dipalmitoylphosphatidyl-
choline (DPPC), pyrene and 1,6-diphenyl-1,3,5-hexatriene (DPH)
were purchased from Wako (Osaka, Japan). Lactose hydrous, sodium
phosphate monobasic, sodium phosphate dibasic and sodium hydrox-
ide were purchased from Mallinckrodt (Paris, KY, USA).
2.2. Evaluation of miscibility of E5531 and DPPC by measurement of
spreading pressure
In order to evaluate the miscibility of E5531, lipid A from Esche-
richia coli (EC), lipid A from Salmonella minnesota (SM) and DPPC
in bulk phase, spreading pressures of the lipid mixtures were meas-
ured. E5531, EC and SM were dissolved in methanol and DPPC were
dissolved in chloroform, respectively, and mixed in a suitable ratio.
After evaporation of the solvent, the dried lipid mixtures were added
to distilled water in a surface tensiometer (Model CBVP-A3, Kyowa
Kaimenkagaku, Tokyo, Japan). The spreading pressures of the lipid
mixtures at an air/water interface (surface pressure of the bulk lipid
mixture) were obtained from the steady value of surface pressure at
1^2 h after addition of the lipid or the lipid mixture to the water.
Spreading pressures were determined at 25‡C. The data are given as
mean values of triplicate measurements. The details of the monolayer
techniques have been described elsewhere [11,12].
2.3. Preparation of the aggregates from E5531/DPPC mixtures
The aggregates from E5531/DPPC, EC/DPPC and SM/DPPC mix-
tures were prepared by the method of Dijkstra et al. [13]. DPPC was
dissolved in chloroform and E5531, EC and SM were dissolved in
methanol. These stock solutions were then mixed at a suitable ratio.
The solvents were evaporated under a stream of nitrogen gas at 70‡C.
The lipid ¢lm was hydrated to give a total concentration of the total
lipids of 1 mM with 4.25 mM phosphate-NaOH bu¡er containing
10% lactose (pH 7.3). The lipid dispersion was then sonicated with
a probe-type sonicator (Tomy Seiko, Tokyo, Japan) at 50‡C for
10 min.
2.4. Determination of the size of the E5531/DPPC aggregates
The size of the aggregates in the lipid mixtures was determined at
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25‡C by dynamic light scattering (DLS) techniques using a laser par-
ticle analyzer (model DLS-7000DL, Ohtsuka Electronics, Osaka, Ja-
pan). The data were analyzed by the histogram method [14] and the
weight-averaged aggregate sizes were evaluated.
2.5. Determination of zeta potential
The zeta potentials of the lipid mixtures were measured at 25‡C
using a model ELS-800 analyzer (Ohtsuka Electronics, Osaka, Japan).
The data are given as mean values of duplicate measurements.
2.6. Determination of the rapped volume in the aggregates of the
E5531/DPPC mixtures
In order to obtain information on the structure of the aggregates in
E5531/DPPC, EC/DPPC and SM/DPPC mixtures, the trapped vol-
ume inside the aggregates was determined using £uorescence techni-
ques [15]. The mixtures was dispersed in 2.5 ml of 70 mM calcein
solution (pH 7.3) with sonication at 50‡C for 60 min and then cooled
to 25‡C. The total lipid concentration was 2 mM.
The untrapped calcein was removed by gel ¢ltration (Sephadex G-
50) at 25‡C. The volume of the calcein solution trapped in the dis-
persed aggregates was determined £uorometrically [16] after solubili-
zation of the lipid aggregates by the addition of 10% Triton X-100,
and the aqueous volume trapped per mol of DPPC was evaluated.
DPPC in the dispersion was assayed by HPLC (detection wavelength
210 nm).
2.7. Determination of the membrane £uidity of the E5531/DPPC
mixtures
The membrane £uidity of the E5531/DPPC, EC/DPPC and SM/
DPPC aggregates was determined using a £uorescence polarization
technique (Probe: DPH) as reported by Iwamoto et al. [17]. DPH
was added at 1 mol% of total lipids. All £uorescence measurements
were carried out using a Model F-4500 £uorescence spectrophotom-
eter (Hitachi, Tokyo, Japan) equipped with a thermoregulated cell
compartment, Atago Coolnics Model REX-C10 (Atago, Tokyo, Ja-
pan). The degree of polarization (P) was calculated using the follow-
ing equation:
P  IVV3Cf WIVH=IVV  Cf WIVH
where I is the £uorescence intensity and subscripts V and H indicate
the vertical and horizontal orientations of excitation (¢rst) and anal-
ysis (second) polarizers, respectively. Cf (= IHV/IHH) is the grating
correction factor.
2.8. Determination of the phase transition temperature by
pyrene di¡usion
In order to determine the phase transition temperature of the
E5531/DPPC, EC/DPPC and SM/DPPC membranes with a method
other than £uorescence polarization (probe: DPH), the £uorescence
spectra of pyrene embedded in E5531/DPPC, EC/DPPC and SM/
DPPC membranes were measured. Pyrene was added at 1 mol% to
total lipid. Measurements were made at increasing temperatures with
an excitation wavelength of 330 nm and emission wavelength of 480
nm. The intensity ratio of the pyrene £uorescence peak (I480/I376) is
the ratio of excimer £uorescence intensity (480 nm, IP) to the mono-
mer £uorescence intensity (376 nm, I) and is reported to correlate with
the di¡usion of pyrene in the lipid membrane [18].
2.9. Thermotropic behavior of E5531/DPPC mixtures
In order to investigate the phase transition of the lipid mixtures,
di¡erential scanning calorimetry (DSC) was performed using a Model
DSC-100 (Seiko-Denshi, Tokyo, Japan). E5531/DPPC, EC/DPPC and
SM/DPPC mixtures (total 1.5U1036 mol) in 40 Wl of 4.25 mM phos-
phate-NaOH, 10% lactose bu¡er (pH 7.3) were placed in a DSC pan
and sealed. An equal volume of the bu¡er solution (pH 7.3) was
placed in the reference pan. Temperature scans were made from
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Fig. 1. a: Chemical structure of the synthetic lipid A analog, E5531. b: Chemical structure of the lipid A from Escherichia coli and Salmonella
minnesota (see also Table 1).
Table 1
Chemical structure of lipid A from Escherichia coli and Salmonella
minnesota
Preparation Chemical nature of
R1 R2 R3
E. coli lipid A P P H
S. minnesota lipid A P- - -AraN P- - -P-EtN 16:0
Dotted lines indicate incomplete subscription. AraN =L-linked 4-ami-
no-4-deoxy-L-arabinopyranose; EtN = ethanolamine; 16:0 = hexadeca-
noyl.
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10‡C to 70‡C with heating rates of 2‡C/min. All calorimetric data
were obtained from samples during the heating phase.
3. Results
3.1. Evaluation of miscibility of E5531 and DPPC
Fig. 2 shows the spreading pressures of E5531/DPPC, EC/
DPPC and SM/DPPC mixtures. The spreading pressure of
hydrated DPPC (lamellar bilayers of DPPC) was 45.0 mN/
m. Those for E5531, EC and SM were 50.0, 51.2 and 52.0
mN/m, respectively. The spreading pressure of a lipid mixture
depends on the miscibility of the lipids in the bulk phases
[19,20]. The spreading pressure of E5531/DPPC, EC/DPPC
and SM/DPPC mixtures varied with the mole fraction of
E5531 in the lipid mixture (XE5531), EC in the mixture (XEC)
and SM in the mixture (XSM). On the basis of the surface
phase rule [12,21] it was concluded that E5531, EC, SM and
DPPC were miscible in the bulk phases, respectively. Based
upon these results, we decided to evaluate the e¡ect of E5531,
EC and SM on DPPC membranes in the range 0^0.5.
3.2. Determination of the size of the aggregates and the zeta
potentials of the E5531/DPPC mixtures
Table 2 shows the weight averaged size of the aggregates of
the E5531/DPPC, EC/DPPC and SM/DPPC mixtures eval-
uated by DLS measurements and their zeta potentials at dif-
ferent XE5531, XEC and XSM. The mean diameters for E5531/
DPPC, EC/DPPC and SM/DPPC mixtures were almost 18, 24
and 25 nm, respectively, and independent of XE5531, XEC and
XSM. The zeta potentials were negative and decreased as
XE5531, XEC and XSM increased. Since E5531, EC and SM
are negatively charged in neutral aqueous solution, the phos-
phate group at the head sugar moiety of E5531, EC and SM
was considered to be at the surface of the lipid membrane and
this group conferred the negative charge on the aggregates.
3.3. Structure of the aggregates in the E5531/DPPC mixtures
Neutral lipids such as K-tocopherol and phosphatidylcho-
line are miscible in the bulk phase and form a bilayer and
hexagonal (HII) phases [22]. E5531, EC or SM and DPPC are
also miscible in the bulk phase and we investigated the phase
structure of E5531/DPPC, EC/DPPC and SM/DPPC mix-
tures. Table 2 represents the volumes of trapped inner space
in the aggregates per mol of the E5531/DPPC, EC/DPPC and
SM/DPPC mixtures. The trapped volumes of small unilamel-
lar vesicles (diameter 20^50 nm), large unilamellar vesicles
(200^1000 nm) and multilamellar vesicles (400^3500 nm) of
phosphatidylcholine have been estimated to be 0.2^0.5, 3^4
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Fig. 2. Spreading pressures of the lipid mixtures at an air/water interface at 25‡C. Each point represents the mean þ S.E.M. of triplicate meas-
urements. a: E5531/DPPC mixtures; b: E. coli/DPPC mixtures; c: S. minnesota/DPPC mixtures.
Table 2
Size of aggregates, zeta potentials and trapped volumes for E5531, Escherichia coli, Salmonella minnesota and DPPC mixtures
Mole fraction of the lipids in the mixtures
0 0.1 0.3 0.5
Size of aggregates (nm)
E5531 18.9 þ 7.9 20.0 þ 7.3 17.4 þ 6.5 19.4 þ 7.9
Escherichia coli 18.9 þ 7.9 24.8 þ 5.2 25.2 þ 3.8 24.3 þ 4.0
Salmonella minnesota 18.9 þ 7.9 25.6 þ 6.1 27.1 þ 4.6 26.5 þ 5.2
Zeta potential (mV)
E5531 31.3 326.9 346.4 358.1
Escherichia coli 31.3 324.8 343.5 355.3
Salmonella minnesota 31.3 325.1 344.8 356.9
Trapped volume (liter/mol)
E5531 0.36 0.36 0.37 0.35
Escherichia coli 0.36 0.45 0.44 0.45
Salmonella minnesota 0.36 0.43 0.47 0.45
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and 7^10 l/mol, respectively [23]. The size of the aggregates of
DPPC liposomes was 18 nm and the trapped volume was 0.36
l/mol. The size of the aggregates and trapped volume of the
E5531/DPPC, EC/DPPC and SM/DPPC mixtures remained
constant over the XE5531, XEC and XSM range of 0^0.5. These
data indicate that within this range E5531/DPPC, EC/DPPC
and SM/DPPC molecules form liposome-like structures (small
unilamellar vesicles) and have a membrane.
3.4. Membrane £uidity of the E5531/DPPC mixtures
The membrane £uidity of the E5531/DPPC, EC/DPPC and
SM/DPPC mixtures were evaluated using £uorescence polar-
ization techniques (Fig. 3). The £uorescence polarization of
DPH in DPPC liposomes decreased markedly around 40‡C,
indicating that the phase transition of the DPPC bilayer from
gel to liquid-crystal state occurs at this temperature. This re-
sult is in good agreement with the reported value [24]. The
phase transition of the lipid mixtures was dependent on
XE5531. At XE5531 = 0.1, 0.3, 0.5, the phase transition temper-
atures were 38, 37 and 33‡C, respectively. As XE5531 increased
the £uorescence polarization decreased. These results indicate
that with the increase in XE5531 a more £uid membrane was
formed and the cooperative interaction between the DPPC
molecules decreased. On the other hand, at XEC = 0.1, 0.3,
0.5, the phase transition temperatures were 44, 46 and 47‡C,
respectively. At XSM = 0.1, 0.3, 0.5, the phase transition tem-
peratures were 42, 43 and 45‡C, respectively. These results
indicate that with the increase in XEC and XEC more rigid
membranes were formed and the cooperative interaction be-
tween the DPPC molecules increased.
3.5. Di¡usion of pyrene in E5531/DPPC membrane
The pyrene £uorescence intensity ratio IP/I was plotted as a
function of the temperature (Fig. 4). The lipid phase transition
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Fig. 3. Relationship between incubation temperature and £uorescence polarization using DPH as a function of the lipid mole fraction in the
lipid mixture. a: E5531/DPPC mixtures; XE5531 = 0 (a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5 (R- - -R). b: E. coli/DPPC mixtures; XEC = 0
(a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5 (R- - -R). c: S. minnesota/DPPC mixtures; XSM = 0 (a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5
(R- - -R).
Fig. 4. Relationship between incubation temperature and IP/I for pyrene di¡usion in the lipid mixtures. a: E5531/DPPC mixtures; XE5531 = 0
(a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5 (R- - -R). b: E. coli/DPPC mixtures; XEC = 0 (a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5
(R- - -R). c: S. minnesota/DPPC mixtures; XSM = 0 (a- - -a), 0.1 (b- - -b), 0.3 (O- - -O), 0.5 (R- - -R).
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is characterized by a sharp decrease in the intensity ratio IP/I
[18]. The IP/I ratio of E5531/DPPC mixtures at XE5531 = 0, 0.1,
0.3 and 0.5 sharply decreased around 41, 39, 36 and 35‡C,
respectively, and these temperatures were suggested to be
phase transition temperatures. On the other hand, the IP/I
ratio of EC/DPPC mixtures at XEC = 0.1, 0.3 and 0.5 sharply
decreased around 44, 45 and 47‡C, respectively. The IP/I ratio
of SM/DPPC mixtures at XSM = 0.1, 0.3 and 0.5 sharply de-
creased around 43, 45 and 47‡C, respectively. These results
are similar to the £uorescence polarization (probe: DPH) re-
sults (Fig. 3). The change in IP/I at the phase transition de-
creases with decreasing pyrene concentration and correlating
with di¡usion coe⁄cients (Ddiff) for lateral di¡usion of pyrene
in lipid membranes [18]. The IP/I at XE5531 = 0, 0.1, 0.3 and 0.5
at 37‡C were 0.43, 0.36, 0.32 and 0.25, indicating that as
XE5531 increases, Ddiff will decrease and there will be a reduc-
tion for the lateral di¡usion. The IP/I at XEC = 0.1, 0.3 and 0.5
at 37‡C were 0.78, 0.93 and 0.99. The IP/I at XSM = 0.1, 0.3
and 0.5 at 37‡C were 0.79, 0.84 and 0.88. These data indicate
that as XEC and XSM increase, Ddiff will increase and there will
be an increase in lateral di¡usion.
3.6. Thermotropic behavior of E5531/DPPC mixtures
The thermotropic behavior of the lipid mixtures was deter-
mined by di¡erential scanning calorimetry (DSC). The ther-
mograms of E5531/DPPC, EC/DPPC and SM/E5531 mixtures
are shown in Fig. 5. The pretransition of DPPC was not
completely abolished at XE5531 = 0.1, rather it was shifted to
a lower temperature as a shoulder in the endothermic peak.
The shape of the main transition of DPPC was not changed at
XE5531 = 0.1. At XE5531 = 0.3, E5531 broadened the half-height
width of the excess heat curve of DPPC, while the curve shape
became asymmetric as the phase transition temperature de-
creased with a shoulder at the higher temperature. Both the
onset and the end of the transition were shifted to lower
temperatures as the concentration of E5531 was increased.
The suppression of the endothermic transition is presented
in Table 3. E5531 decreased the phase transition enthalpy of
the DPPC membrane. On the other hand, the addition of EC
and SM increased the phase transition temperature. These
¢ndings obtained from EC were similar to the lipid A from
Escherichia coli K-12 cells [25] and this lipid A increased the
phase transition temperature of DPPC membrane.
4. Discussion
Lipid A is a complex macromolecule which produces a
number of pathophysiological events when introduced into
the bloodstream of higher animals. For the mechanism re-
sponsible for the initiation of various biological responses
during endotoxin shock, it has been proposed that lipid A
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Fig. 5. DSC thermogram of the lipid mixtures. Scan speed was 2‡C/min and temperature ranged from 10‡C to 60‡C. a: E5531/DPPC mixtures.
b: E. coli/DPPC mixtures. c: S. minnesota/DPPC mixtures.
Table 3
Phase transition temperature and enthalpy for E5531, Escherichia
coli, Salmonella minnesota and DPPC mixtures
Mole fraction of the lipids in the
mixtures
0 0.1 0.3 0.5
Phase transition temperature determined by DSC (‡C)
E5531 33.1 36.0 37.4 32.4
40.6
Escherichia coli 33.1 42.3 45.1 47.8
40.6
Salmonella minnesota 33.1 41.2 44.6 45.8
40.6
Phase transition enthalpy determined by DSC (kJ/mol)
E5531 2.7 36.6 13.2 6.5
35.8
Escherichia coli 2.7 30.1 25.3 17.8
35.8
Salmonella minnesota 2.7 29.5 26.8 23.4
35.8
Phase transition temperature determined by £uorescence polarization
(probe: DPH) (‡C)
E5531 40 38 37 33
Escherichia coli 40 44 46 47
Salmonella minnesota 40 42 43 45
Phase transition temperature determined by pyrene di¡usion (‡C)
E5531 41 39 36 35
Escherichia coli 41 44 45 47
Salmonella minnesota 41 43 45 47
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triggers its noxious e¡ects by acting speci¢cally on a receptor
site [26], or non-speci¢cally through membrane lipids [9,27].
Regarding the latter concept, Jacobs [28] has shown that lipid
A associates with cells in a manner that is suggestive of a two-
step process. The ¢rst step is ionic in nature. Based on the
results from zeta potentials measurements, E5531, EC and SM
gave a negative charge to DPPC membranes. However, it is
not known whether such charge-mediated interaction can pro-
vide an activation signal to cells from the cell surface. The
charge-mediated association of macromolecules with cell sur-
faces inactivates, rather than activates, cells in one system [29].
The second of these steps, proposed to be the intercalation of
the lipid A into the membrane lipid bilayer, is not unexpected
since lipid A interacts with phospholipid monolayers [30]. The
intrusion of such a large segment of lipid would be expected
to alter the order of £uidity of the membrane lipid bilayer.
Indeed, lipid bilayers that are reconstituted with lipopolysac-
charide or lipid A are less £uid than reconstituted bilayers
consisting of the lipid alone [25]. Therefore, we designed a
test system to examine whether or not E5531 could interact
with a membrane bilayer to alter its £uidity.
In this study, we concluded from our results that E5531
interacted with the lipid bilayer and increased the £uidity of
that bilayer. On the other hand, the addition of EC and SM
decreased the membrane £uidity of the bilayer. In the case of
lipopolysaccharide, cell activation is associated with changes
in cell membrane £uidity [31,32]. It will be assumed that the
intercalation of E5531 increased the £uidity of that region of
the cell membranes and that the biological action of E5531
and the molecular mechanism of E5531 interaction with cell
membranes will be di¡erent from those of EC and SM. Christ
et al. [10] have reported that E5531 is a lipid A antagonist and
will bind the LPS receptor, and the a⁄nity of E5531 to bind
the receptor is larger than that for lipid A. Kawata et al. [33]
have also reported that E5531 blocked the induction of TNF-
K by LPS and reduced LPS-induced lethality in mice. Based
upon the results from our study and these reports, it is as-
sumed that these useful e¡ects of E5531 are obtained not only
from the di¡erence in the a⁄nity to the LPS receptor but also
from the di¡erence in the interaction to the cell membrane. In
other words, E5531 will bind speci¢cally on a receptor site,
and in addition it will intercalate non-speci¢cally through
membrane lipids and give the useful biological e¡ects.
References
[1] Vogel, S.N., Madonna, G.S., Wahl, L.M. and Rick, P.D. (1984)
J. Immunol. 132, 347^353.
[2] Galanos, C., Lederits, O., Rietschel, E.T. and Westpheal, O.
(1985) Eur. J. Biochem. 148, 1^5.
[3] Lei, M.G. and Morrinson, D.C. (1988) J. Immunol. 141, 998^
1005.
[4] Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and
Mathison, J.C. (1990) Science 249, 1431^1433.
[5] Larsen, N.E., Enelow, R.I., Simons, E.R. and Sullivian, R.
(1985) Biochim. Biophys. Acta 815, 1^8.
[6] Brundenburg, K., Mayer, H., Koch, M.H.J., Wecjesser, J.,
Rietchel, E.T. and Sedel, U. (1993) Eur. J. Biochem. 218, 555^
563.
[7] Rottem, S. (1978) FEBS Lett. 95, 121^124.
[8] Liu, M., Onji, T. and Snelgrove, N.E. (1982) Biochim. Biophys.
Acta 710, 248^251.
[9] Benedetto, D.A., Shands, J.W. and Shah, D.O. (1973) Biochim.
Biophys. Acta 298, 145^157.
[10] Christ, W.J., Asano, O., Robidoux, A.L., Perez, M., Wang, Y.,
Dobuc, G.R., Gavin, W.E., Hawkins, L.D., McGuinness, P.D.,
Mullarkey, M.A., Lewis, P.D., Kishi, Y., Kawata, T., Bristol,
J.R., Rose, J.R., Rossignol, D.P., Kobayashi, S., Hishinura, I.,
Kimura, A., Asakawa, N., Katayama, K. and Yamatsu, I. (1995)
Science 268, (5207) 80^83.
[11] Handa, T., Ichihashi, C. and Nakagaki, M. (1985) Prog. Colloid
Polymer Sci. 71, 26^31.
[12] Nakagaki, M., Tomita, K., Handa, T. and Miyajima, K. (1985)
Biochemistry 24, 4619^4624.
[13] Dijkstra, J., Mellors, J.W., Ryan, J.L. and Szoka, F.C. (1987)
J. Immunol. 138, 2663^2667.
[14] Gulari, E., Gulari, E., Tsunashima, Y. and Chu, B. (1979)
J. Chem. Phys. 70, 3965^3972.
[15] Oku, N., Kendalll, D.A. and MacDonald, R.C. (1982) Biochim.
Biophys. Acta 691, 332^340.
[16] Allen, T.M. and Cleland, L.G. (1980) Biochim. Biophys. Acta
597, 418^426.
[17] Iwamoto, K., Sunamoto, J., Inoue, K., Endo, T. and Nojima, S.
(1982) Biochim. Biophys. Acta 691, 44^51.
[18] Galla, H.J. and Sackmann, E. (1974) Biochim. Biophys. Acta
339, 103^115.
[19] Nakagaki, M. and Funakoshi, N. (1974) Bull. Chem. Soc. Jpn.
47, 2482^2485.
[20] Handa, T., Saito, H. and Miyajima, K. (1990) Biochemistry 29,
2884^2890.
[21] Defy, R., Prigogine, I., Bellmans, A. and Everett, D.E. (1966)
Surface Tension and Adsorption, pp.71^84, Longmans Green,
London.
[22] Nakajima, K., Utsumi, H., Kazama, M. and Hamada, A. (1990)
Chem. Pharm. Bull. 38, 1^4.
[23] Szoka Jr., F. and Papahadjopoulos, D. (1978) Proc. Natl. Acad.
Sci. USA 75, 4194^4198.
[24] Van Dijck, P.W.M., De Kruij¡, B., Van Deenen, L.L.M., De
Gier, J. and Demel, R.A. (1976) Biochim. Biophys. Acta 455,
576^587.
[25] Mackay, A.L., Nichol, C.P., Weeks, G. and Davis, J.H. (1984)
Biochim. Biophys. Acta 774, 181^187.
[26] Springer, G.F., Adye, J.C., Benzkorovainy, A. and Murthy, J.R.
(1973) J. Infect. Dis. 128 Suppl., S202^S212.
[27] Pagani, R., PortoleŁs, M.T. and Municio, A.M. (1981) FEBS Lett.
131, 103^107.
[28] Jacobs, D.M. (1984) Rev. Infect. Dis. 6, 501^505.
[29] Price, R.M., Gersten, D.M. and Ramwell, P.W. (1985) Biochim.
Biophys. Acta 597, 502^517.
[30] Fried, V.A. and Roth¢eld, L.I. (1978) Biochim. Biophys. Acta
514, 69^82.
[31] Salesse, R. and Garnier, J. (1984) Mol. Cell. Biochem. 60, 17^31.
[32] Quinn, P.J. (1981) Prog. Biophys. Mol. Biol. 38, 1^104.
[33] Kawata, T., Bristol, J.R., Rose, J.R., Rossignol, D.P., Christ,
W.J., Asano, O., Dubuc, G.R., Gavin, W.E., Hawkins, L.D.
and Kishi, Y. (1995) Prog. Clin. Biol. Res. 392, 499^504.
FEBS 21020 2-11-98
Y. Asai et al./FEBS Letters 438 (1998) 15^2020
